MARKET

EDAP

EDAP

Edap Tms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.16
+0.26
+3.70%
Opening 15:12 05/18 EDT
OPEN
7.00
PREV CLOSE
6.90
HIGH
7.25
LOW
6.98
VOLUME
80.25K
TURNOVER
229.81K
52 WEEK HIGH
7.88
52 WEEK LOW
5.00
MARKET CAP
239.45M
P/E (TTM)
503.87
1D
5D
1M
3M
1Y
5Y
EDAP TMS S.A. GAAP EPS of $0.01 beats by $0.04, revenue of $14.53M beats by $1.62M
EDAP TMS S.A. press release (NASDAQ:EDAP): Q1 GAAP EPS of $0.01 beats by $0.04. Revenue of $14.53M (+17.7% Y/Y) beats by $1.62M. Gross profit margin on net sales was 44.3
Seekingalpha · 22h ago
BRIEF-Edap Reports First Quarter 2022 Results
reuters.com · 22h ago
EDAP TMS Posts Lower Q1 Profit Amid Rising Revenue
MT Newswires · 1d ago
Notable earnings after Tuesday's close
DLO, DOCS, EDAP, KEYS, NXGN, QUIK, TCS For Seeking Alpha's full earnings season calendar, click here.
Seekingalpha · 1d ago
EDAP TMS S.A. Q1 2022 Earnings Preview
EDAP TMS S.A. (NASDAQ:EDAP) is scheduled to announce Q1 earnings results on Tuesday, May 17th, after market close. The consensus EPS Estimate is -$0.03 (-200.0% Y/Y) and the consensus Revenue
Seekingalpha · 1d ago
Earnings Preview: Edap TMS
Edap TMS (NASDAQ:EDAP) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Edap TMS will report an earnings per share (EPS) of $-0.03.
Benzinga · 2d ago
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from mid-cap companies.
Benzinga · 2d ago
EDAP TMS SA to Announce First Quarter 2022 Financial Results on May 17, 2022
Company to host conference call and webcast on, Wednesday, May 18th at 8:30 am EDT LYON, France, May 10, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that it will release its financial results for ...
GlobeNewswire · 05/10 12:30
More
No Data
Learn about the latest financial forecast of EDAP. Analyze the recent business situations of Edap Tms through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average EDAP stock price target is 12.04 with a high estimate of 13.05 and a low estimate of 11.04.
High13.05
Average12.04
Low11.04
Current 7.16
EPS
Actual
Estimate
-0.010.010.030.04
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Institutional Holdings
Institutions: 43
Institutional Holdings: 10.18M
% Owned: 30.42%
Shares Outstanding: 33.47M
TypeInstitutionsShares
Increased
4
651.86K
New
4
55.48K
Decreased
9
87.04K
Sold Out
7
448.63K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-1.64%
Healthcare Equipment & Supplies
-2.02%
Key Executives
Chairman/Chief Executive Officer/Director
Marc Oczachowski
Chief Financial Officer
Francois Dietsch
Independent Director
Pierre Beysson
Independent Director
Marie Meynadier
Independent Director
Rob Michiels
Independent Director
Argil Wheelock
No Data
No Data
About EDAP
EDAP TMS S.A. (EDAP) is a company that develops, manufactures, promotes and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology. The Company operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The Company invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The Company is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The Company is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.

Webull offers kinds of Edap Tms SA (ADR) stock information, including NASDAQ:EDAP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDAP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EDAP stock methods without spending real money on the virtual paper trading platform.